<DOC>
	<DOC>NCT01186133</DOC>
	<brief_summary>The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.</brief_summary>
	<brief_title>Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice</brief_title>
	<detailed_description>Consecutive patients receiving New DES without a mixture of other DES</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>coronary disease amenable to percutaneous coronary intervention (PCI) no clinical and lesion limitations patients with a mixture of several DES terminal illness with life expectancy less than 1 year patients with cardiogenic shock</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>coronary disease</keyword>
	<keyword>drug eluting stent</keyword>
</DOC>